PLx Pharma Inc. (PLXP)

NASDAQ: PLXP · IEX Real-Time Price · USD
3.02
0.10 (3.42%)
May 17, 2022 4:00 PM EDT - Market closed
Market Cap83.17M
Revenue (ttm)10.29M
Net Income (ttm)-47.57M
Shares Out27.54M
EPS (ttm)-2.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume183,217
Open3.00
Previous Close2.92
Day's Range2.77 - 3.13
52-Week Range1.93 - 21.50
Beta4.44
AnalystsBuy
Price Target16.66 (+451.7%)
Earnings DateMay 13, 2022

About PLXP

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which a...

IndustryPharmaceuticals
Founded2002
Employees16
Stock ExchangeNASDAQ
Ticker SymbolPLXP
Full Company Profile

Financial Performance

In 2021, PLx Pharma's revenue was $8.21 million, an increase of 27,260.00% compared to the previous year's $30,000. Losses were -$46.13 million, 203.2% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for PLXP stock is "Buy." The 12-month stock price forecast is 16.66, which is an increase of 451.66% from the latest price.

Price Target
$16.66
(451.66% upside)
Analyst Consensus: Buy
Stock Forecasts

News

PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates

PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 4.35% and 11.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 days ago - Zacks Investment Research

PLx Pharma Inc. Reports First Quarter 2022 Results and Provides Business Update

BUILDING A SOLID BASE OF VAZALORE ® USERS

4 days ago - GlobeNewsWire

PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business ...

SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validat...

3 weeks ago - GlobeNewsWire

Dipexium Pharmaceuticals, Inc. (PLXP) Reports Q4 Loss, Misses Revenue Estimates

Dipexium Pharmaceuticals, Inc. (PLXP) delivered earnings and revenue surprises of -5.80% and 17.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for t...

2 months ago - Zacks Investment Research

PLx Pharma Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

Momentum Building for Novel Vazalore ® Liquid-Filled Aspirin Capsules

2 months ago - GlobeNewsWire

PLx Pharma Inc. to Present at Oppenheimer & Co's 32nd Annual Healthcare Conference on March 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validat...

2 months ago - GlobeNewsWire

PLx Pharma Inc. to Discuss 2021 Fourth Quarter Financial Results on March 11, 2022 Conference Call and Provide Busine...

SPARTA, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validate...

2 months ago - GlobeNewsWire

PLx Pharma Inc. Proudly Celebrates Go Red for Women Day® 2022 to Support Heart Health Awareness

-- Female-Led Company Strives to Transform Standard of Care  in Secondary Prevention of Heart Attack or Clot-Related Stroke  with its Innovative New Aspirin Formulation VAZALORE ® -- SPARTA, N. J., Feb....

3 months ago - GlobeNewsWire

PLx Pharma Inc. Appoints Janet Barth to Newly Created Role of Vice President, Investor Relations & Corporate Communic...

SPARTA, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validat...

3 months ago - GlobeNewsWire

Implied Volatility Surging for Dipexium Pharmaceuticals (PLXP) Stock Options

Investors need to pay close attention to Dipexium Pharmaceuticals (PLXP) stock based on the movements in the options market lately.

5 months ago - Zacks Investment Research

PLx Pharma Inc. to Present at Piper Sandler 33rd Annual Healthcare Conference 2021

SPARTA, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validate...

5 months ago - GlobeNewsWire

PLx Pharma Inc. Reports Third Quarter 2021 Results and Provides Business Update

-- Results demonstrate strong execution of initial phase of VAZALORE commercial launch, including shipments to 30,000+ stores nationwide and e-commerce sites -- -- Reported net revenue of $6.6 million i...

6 months ago - GlobeNewsWire

PLx Pharma Inc. Announces New Scientific Data Available Evaluating the Pharmacologic Profile of FDA-Approved VAZALORE...

-- VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition -- -- VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent withVAZALORE 325 mg --

6 months ago - GlobeNewsWire

PLx Pharma Inc. to Discuss 2021 Third Quarter Financial Results on November 12, 2021 Conference Call and Provide Busi...

SPARTA, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PL...

6 months ago - GlobeNewsWire

PLx Pharma Inc. Provides VAZALORE Launch Update

-- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites -- -- Launch in line with expectations and exceptionally positive feedback from consumers and healthcare professionals received --

6 months ago - GlobeNewsWire

PLx Pharma stock drops again, and company looks to clarify USPTF's recent comments about aspirin use

Shares of PLx Pharma Inc. PLXP, -9.41% dropped 9.2% in afternoon trading Thursday, but nearly halved their earlier loss, as the drug maker responded to recently raised concerns over the use of aspirin t...

7 months ago - Market Watch

PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardio...

Aspirin remains an established practice for the prevention of another heart attack or clot-related stroke Aspirin remains an established practice for the prevention of another heart attack or clot-relat...

7 months ago - GlobeNewsWire

PLx Pharma Inc. to Present at Upcoming Virtual Healthcare Industry Conferences

SPARTA, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxG...

8 months ago - GlobeNewsWire

PLx Pharma Inc.'s VAZALORE™ Now on Shelves; National Media Campaign Launches Today

-- Executing broad reach television advertising to support the launch of VAZALORE -- -- Media campaign reach matches extensive distribution at retailers --

8 months ago - GlobeNewsWire

PLx Pharma Inc. Reports Second Quarter 2021 Results and Provides Business Update

--Walmart, Walgreens, Rite Aid, CVS and many other retailers placing VAZALORE on shelves later this month-- --VAZALORE launch inventory manufactured and currently shipping to retailers across the country--

9 months ago - GlobeNewsWire

PLx Pharma Inc.'s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month

Shelf space for all three SKUs of VAZALORE is reserved with “Coming Soon” shelf placeholders Shelf space for all three SKUs of VAZALORE is reserved with “Coming Soon” shelf placeholders

9 months ago - GlobeNewsWire

PLx Pharma Inc.'s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August

-- ‘Coming Soon' placeholders for all three SKUs of VAZALORE to be positioned prominently on shelves -- -- ‘Coming Soon' placeholders for all three SKUs of VAZALORE to be positioned prominently on shelv...

9 months ago - GlobeNewsWire

PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Busine...

SPARTA, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGu...

9 months ago - GlobeNewsWire

Why PLx Pharma Blasted Nearly 20% Higher Today

The company is on a roll, scoring its second major retail distribution deal in as many weeks.

9 months ago - The Motley Fool

PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

-- Shelf space for all three SKUs of VAZALORE is being reserved with ‘Coming Soon' shelf placeholders -- -- Shelf space for all three SKUs of VAZALORE is being reserved with ‘Coming Soon' shelf placehol...

9 months ago - GlobeNewsWire